Buy BSV slightly over 77.02 target 77.69 stop loss @ 76.8 Short BSV slightly under 77.69, target 77.02, stop loss @ 77.91 Check the time stamp on this data. Updated AI-Generated Signals for Vanguard …
A&O Shearman, Hogan Lovells to Defend £9.9 Billion Crypto Class Action
Lawyers for the claimants have accused six crypto exchanges of “colluding to delist BSV from their exchanges” in 2019.
Bitcoin SV Price Eyes 2X Gains Amid BTC Correction
Bitcoin SV price surged for the past week, gaining 18.4% and outperforming its predecessor, Bitcoin. The price surge may have resulted from the Bitcoin …
Bitcoin Cash, BSV skyrocket 14% post Trump’s pro-crypto vows
BTC-linked tokens are witnessing a rally, riding on Bitcoin’s latest attempt to regain the $70,000 mark after Donald Trump’s pro-crypto speech at the Bitcoin Conference. Bitcoin Cash (BCH) and Bitcoin …
Market not much enthused by Mankind’s BSV buy
After initially cheering the deal, the stock market gave its thumbs-down to Mankind acquiring BSV at the premium valuations of eight times its FY24 revenues and 23 times its estimated ebitda of FY25.
Bitcoin SV
SEOUL – Bitcoin SV (BSV) has seen a dramatic increase in value, with its price more than doubling due to a surge in trading activity on the South Korean Upbit exchange. The… Discover what crypto …
In its biggest acquisition, Mankind Pharma tries to replicate its past success in M&A
Further, the management said the acquisition should not dilute the profitability and return ratios. Bharat Serums and Vaccines (BSV) meets most of the conditions, except that it is the biggest acquisition the company will be
BSV portfolio can touch Rs 5K cr in 3-4 yrs: Mankind Pharma’s Rajeev Juneja
We don’t want to get into exports with generic or me-too products. We always wanted products with a high level of entry barriers and complexity’
Bitcoin Beach co-founder claims Bitcoiners want to move families to El Salvador
Roman Martinez, the co-founder of Bitcoin Beach, claimed people were considering El Salvador a more affordable place to raise families and buy homes “living in a Bitcoin standard.” …
Indian Billionaire Brothers’ Mankind Pharma To Buy Bharat Serums For $1.6 Billion
Mankind Pharma—owned by Indian billionaire brothers Ramesh and Rajeev Juneja— has agreed to buy Bharat Serums and Vaccines for $1.6 billion from Boston-based private equity firm Advent International.
Mankind to use debt, internal accruals to fund BSV buyout
Mankind Pharma announced a ₹13,630 crore acquisition of Bharat Serums and Vaccines (BSV) to be funded through internal accruals and a mix of debt and equity. This strategic move will make them leaders …
Mankind Pharma acquires Bharat Serums and Vaccines for $1.6bn
Mankind Pharma has announced a definitive agreement for the acquisition of Bharat Serums and Vaccines (BSV) for Rs136.3bn ($1.6bn).
Mankind Pharma to lead Indian women’s health market after BSV deal
BSV draws around 46 per cent of revenues from international markets, with the remainder from the Indian market. Rajeev Juneja, vice chairman and managing director, Mankind Pharma, said that BSV’s portfolio allows them to enter the branded international business with products that have a high entry barrier or are considered superspeciality.
Mankind Pharma to acquire 100 percent stake in BSV; Plans to expand high entry barrier portfolio
Mankind Pharma Limited on Friday announced that it has entered into a definitive agreement to acquire a 100 percent stake in Bharat Serums and Vaccines Limited (BSV) from Advent International, one of …
BSV Aug 2024 77.000 put (BSV240816P00077000)
As of July 22 at 11:42 AM EDT. Market Open.
Mankind trumps EQT-ADIA to buy BSV for $1.67 bn
Mankind Pharma, India’s fourth largest pharmaceutical company by market share, has entered into a definitive agreement to acquire Bharat Serums and Vaccines (BSV) from Advent International for around Rs 14,
Mankind Pharma to acquire BSV for ₹13,630 crore
Mankind Pharma Ltd said it had entered into a definitive agreement to acquire a 100% stake in Bharat Serums and Vaccines Ltd (BSV) from private equity firm Advent International for an enterprise value of about ₹13,630 crore subject to closing related …
Mankind Pharma clinches Bharat Serums deal for $1.64 billion
Mankind Pharma acquires Bharat Serums and Vaccines from Advent International for over ₹14,000 crore, expanding its product portfolio.
Morning Scan: All the big stories to get you started for the day
Mankind in race with EQT-ADIA to acquire BSV Group for around Rs 14,000 crore Mankind Pharma is vying with a consortium of EQT and Abu Dhabi Investment Authority to acquire BSV Group from Advent International for around Rs 14,
Solo Bitcoin Miner Beats the Odds, Bagging $200K Reward
Another lone Bitcoin miner has managed to process a block on the largest cryptocurrency’s network—earning a $210,000 reward.
Mankind Pharma trumps EQT-ADIA, set to acquire BSV for $1.6 billion
This is the largest acquisition by Mankind Pharma, India’s 4th largest pharma company by market share. A formal announcement regarding the deal is likely by this week.